To study the efficacy of two antiviral drugs for the treatment of Glenmark Kovid-19

Must Read

Men produce more antibodies than women: study

Listen: Portuguese researchers say that on average men produce more code 19 antibodies than women. He added that...

36 stores were sealed in KP for storing flour and sugar

At least 36 stores in Khyber Pakhtunkhwa have been sealed for stockpiling flour, sugar and rice. The flour...

Joe Biden promises to provide free COVID-19 vaccine to everyone in America if he is elected as President

Washington: Democratic presidential nominee Joe Biden vows that if elected as president in the November 3 election, he will...

Let’s Start this Interesting Article Shared on DesiNew.xyz

New Delhi: Glenmark Pharmaceuticals said on Tuesday that it will conduct a new study to test the combined efficacy of two antiviral drugs, favipirvir and umifenovir, as a potential COVID-19 treatment regimen.
The two antiviral drugs have different mechanisms of action, Glenmark said in a statement, and their combination may demonstrate improved treatment efficacy by effectively coping with high viral loads in early stage COVID-19 patients. Can.
The Glenmark study will examine whether early administration of a combination of favipirvir and umifenovir, both acting by different mechanisms, increases antiviral efficacy on COVID-19 patients, the pair added.
Said Monica Tandon, vice president and head, Glenmark Clinical Development Global Global / Branded Portfolio.
He said that the company hoped the study would be important to identify highly effective and safe treatments against COVID-19 in India.
Glenmark is already conducting phase 3 clinical trials of favipirvir as a COVID-19 monotherapy option with 150 patients enrolled from nine major government and private hospitals in the country.
The results of the monotherapy phase 3 clinical trial are expected by July or August.
The Mumbai-based drug firm was the first unit in the country to receive Drug Controller General of India (DCGI) approval for conducting favipirvir clinical trials against COVID-19.

STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

Men produce more antibodies than women: study

Listen: Portuguese researchers say that on average men produce more code 19 antibodies than women. He added that...

36 stores were sealed in KP for storing flour and sugar

At least 36 stores in Khyber Pakhtunkhwa have been sealed for stockpiling flour, sugar and rice. The flour mill has been sealed and...

Joe Biden promises to provide free COVID-19 vaccine to everyone in America if he is elected as President

Washington: Democratic presidential nominee Joe Biden vows that if elected as president in the November 3 election, he will be free to all Americans,...

Migratory bird species face extinction, need for global security: UN treaty chief

New Delhi: There is a threat of extinction of migratory bird species globally. There should be international cooperation. Its executive secretary Amy...

PML-N has ‘broken the shackles of fear’: Maryam Nawaz

PML-N Vice President Maryam Nawaz talking to her party workers in Quetta on October 24, 2020. - Photo: Screen Grab / Geo TV...
- Advertisement -

More Articles Like This

- Advertisement -